Human hepatic HepaRG cells maintain an organotypic phenotype with high intrinsic CYP450 activity/metabolism and significantly outperform standard HepG2/C3A cells for pharmaceutical and therapeutic applications

Leonard Nelson, Katie Morgan, Philipp Treskes, Kay Samuel, Catherine J Henderson, Claire LeBled, Natalie Homer, M Helen Grant, Peter C. Hayes, John Plevris

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalBasic and Clinical Pharmacology and Toxicology
Early online date10 Jun 2016
Publication statusE-pub ahead of print - 10 Jun 2016

Cite this